Natural history study for Duchenne muscular dystrophy in the UK
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study follows people with Duchenne muscular dystrophy (a muscle-weakening condition) to track how the disease progresses over time. By collecting this data, researchers hope to better understand the condition and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Duchenne muscular dystrophy through genetic testing or a muscle biopsy.
- You must be living in the United Kingdom.
- You can still take part if you are in another clinical trial or have had surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows boys with Duchenne muscular dystrophy over time to better understand how the condition changes and how standard treatments affect health and function. It does not appear to test a new medicine, but it may help doctors plan better future care and studies.
This study tracks the natural history of Duchenne Muscular Dystrophy over time. It collects information from patients at four centers to better understand how the disease progresses, which may help improve care in the future.
This is a research study that follows people with Duchenne muscular dystrophy and female genetic carriers to better understand the condition. It may help researchers measure health patterns over time, which can support future treatments.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
This study collects blood and, for some people, muscle tissue to look for signs (biomarkers) that can help track and better understand myotonic dystrophy. You may help by providing samples and basic muscle function testing, depending on your age and condition type.
Hear when a new Duchenne Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.